These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17452163)

  • 21. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy.
    Jansen AH; Bracke F; van Dantzig JM; Peels KH; Post JC; van den Bosch HC; van Gelder B; Meijer A; Korsten HH; de Vries J; van Hemel NM
    Eur J Echocardiogr; 2008 Jul; 9(4):483-8. PubMed ID: 17826355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy.
    Van de Veire NR; Bleeker GB; De Sutter J; Ypenburg C; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart; 2007 Sep; 93(9):1034-9. PubMed ID: 17309912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined myocardial deformation to predict cardiac resynchronization therapy response in nonischemic cardiomyopathy.
    Yang N; Liang ZG; Wang ZJ; Liu H; Chi C; Tian YF; Qi SH; Wang BY; Han W
    Pacing Clin Electrophysiol; 2017 Sep; 40(9):986-994. PubMed ID: 28691201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.
    Soliman OI; van Dalen BM; Theuns DA; ten Cate FJ; Nemes A; Jordaens LJ; Geleijnse ML
    J Diabetes Complications; 2009; 23(5):365-70. PubMed ID: 18572420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tissue Doppler and color M-mode imaging for evaluation of diastolic function in ambulatory patients with LV systolic dysfunction.
    Rovner A; Waggoner AD; Mathews SJ; Dávila-Román VG; de las Fuentes L
    Echocardiography; 2007 May; 24(5):478-84. PubMed ID: 17456066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapy.
    Jansen AH; van Dantzig Jm; Bracke F; Meijer A; Peels KH; van den Brink RB; Cheriex EC; Delemarre BJ; van der Wouw PA; Korsten HH; van Hemel NM
    Am J Cardiol; 2007 Apr; 99(7):966-9. PubMed ID: 17398193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.
    Penicka M; Bartunek J; De Bruyne B; Vanderheyden M; Goethals M; De Zutter M; Brugada P; Geelen P
    Circulation; 2004 Mar; 109(8):978-83. PubMed ID: 14769701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy.
    Verbrugge FH; Verhaert D; Grieten L; Dupont M; Rivero-Ayerza M; De Vusser P; Van Herendael H; Reyskens R; Vandervoort P; Tang WH; Mullens W
    Europace; 2013 Dec; 15(12):1747-56. PubMed ID: 23821473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pacing transmural scar tissue reduces left ventricle reverse remodeling after cardiac resynchronization therapy.
    Mele D; Agricola E; Monte AD; Galderisi M; D'Andrea A; Rigo F; Citro R; Chiodi E; Marchese G; Valentina PD; Calabrese A; Ferrari R
    Int J Cardiol; 2013 Jul; 167(1):94-101. PubMed ID: 22225709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cardiac resynchronization therapy on left ventricular diastolic function: implications for clinical outcome.
    Doltra A; Bijnens B; Tolosana JM; Gabrielli L; Castel MÁ; Berruezo A; Brugada J; Mont L; Sitges M
    J Card Fail; 2014 May; 20(5):377.e1-7. PubMed ID: 25089305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of left ventricular lead placement in cardiac resynchronization therapy to left ventricular reverse remodeling and to diastolic dyssynchrony.
    Rovner A; de las Fuentes L; Faddis MN; Gleva MJ; Dávila-Román VG; Waggoner AD
    Am J Cardiol; 2007 Jan; 99(2):239-41. PubMed ID: 17223425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Sénéchal M; Lancellotti P; Magne J; Garceau P; Champagne J; Philippon F; O'Hara G; Moonen M; Dubois M
    Am J Cardiol; 2010 Jul; 106(1):31-7. PubMed ID: 20609643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of early diastolic mitral annular velocity and flow propagation velocity in detection of mild to moderate left ventricular diastolic dysfunction.
    Palecek T; Linhart A; Bultas J; Aschermann M
    Eur J Echocardiogr; 2004 Jun; 5(3):196-204. PubMed ID: 15147662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
    Horwich T; Foster E; De Marco T; Tseng Z; Saxon L
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1284-9. PubMed ID: 15574179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization.
    Adelstein E; Schwartzman D; Gorcsan J; Saba S
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):905-11. PubMed ID: 21332868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern.
    Salukhe TV; Francis DP; Clague JR; Sutton R; Poole-Wilson P; Henein MY
    Int J Cardiol; 2005 Apr; 100(1):5-12. PubMed ID: 15820279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.